INVO Bioscience, Inc. — Form D/A

INVO Bioscience, Inc. of SARASOTA, FL, a company, filed a Form D amendment with the SEC on 2023-03-06. The offering totals $500K, of which $500K was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (21)

NameRoleLocation
Jeffrey SegalDirectorSarasota, FL
Rebecca MessinaDirectorSeal Beach, CA
Trent DavisDirectorFRISCO, TX
Michael CampbellExecutive OfficerNewport Beach, CA
Matthew SzotDirectorPonte Vedra, FL
Andrea GorenExecutive OfficerSarasota, FL
Steven ShumDirectorSarasota, FL
Steven ShumExecutive OfficerSarasota, FL
Barbara RyanDirectorSarasota, FL
Debra T HoopesExecutive OfficerSarasota, FL
Kevin DoodyDirectorSarasota, FL
Steven T ShumDirectorMedford, MA
Robert J BowdringDirectorMedford, MA
Robert J BowdringExecutive OfficerMedford, MA
Kevin J DoodyDirectorMedford, MA
Kathleen T KarloffDirectorMedford, MA
Kathleen T KarloffExecutive OfficerMedford, MA
Michael J CampbellDirectorSandy Springs, GA
Michael J CampbellExecutive OfficerSandy Springs, GA
Claude J RanouxExecutive OfficerBeverly, MA
Kathleen J KarloffExecutive OfficerBeverly, MA

Other filings by this issuer (7)

FiledFormOfferingSold
2023-04-06D$3.0M$3.0M
2023-02-17D$500K$300K
2023-01-11D$3.5M$275K
2020-07-15D/A$3.5M$3.5M
2020-05-28D$3.5M$2.1M
2018-01-24D$1.5M$15K
2009-10-14D$545K$545K

More